Glucagon-like peptide 2

DRUG2 trials

Sponsors

Alberta Children's Hospital, University Hospital, Gentofte, Copenhagen

Conditions

Endocrine or Metabolic DiseaseGlucose Metabolism DisordersIntestinal FailureShort Bowel Syndrome

Phase 1

Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure

TerminatedNCT01573286

Alberta Children's HospitalIntestinal Failure, Short Bowel Syndrome

Start: 2012-01-31End: 2015-08-31Updated: 2014-12-23

Unknown Phase

Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?

CompletedNCT03954873

University Hospital, Gentofte, CopenhagenEndocrine or Metabolic Disease, Glucose Metabolism Disorders

Start: 2019-01-31End: 2020-06-01Updated: 2020-11-04